SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 107 filers reported holding SANA BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,192 | -11.0% | 7,026,141 | +37.1% | 0.00% | 0.0% |
| Q2 2023 | $30,536 | +107.0% | 5,123,428 | +13.6% | 0.00% | +100.0% |
| Q1 2023 | $14,751 | -12.4% | 4,510,786 | +5.8% | 0.00% | -33.3% |
| Q4 2022 | $16,844 | -99.9% | 4,264,492 | +17.1% | 0.00% | -25.0% |
| Q3 2022 | $21,844,000 | +17.5% | 3,640,503 | +25.9% | 0.00% | +100.0% |
| Q2 2022 | $18,593,000 | +9.8% | 2,891,581 | +41.0% | 0.00% | 0.0% |
| Q1 2022 | $16,934,000 | -9.2% | 2,050,133 | +70.2% | 0.00% | 0.0% |
| Q4 2021 | $18,649,000 | -30.2% | 1,204,696 | +1.5% | 0.00% | -33.3% |
| Q3 2021 | $26,734,000 | +14.3% | 1,187,109 | -0.3% | 0.00% | +50.0% |
| Q2 2021 | $23,399,000 | -42.1% | 1,190,199 | -1.4% | 0.00% | -50.0% |
| Q1 2021 | $40,389,000 | – | 1,206,710 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Trustees of Columbia University in the City of New York | 281,250 | $6,334,000 | 9.69% |
| Flagship Pioneering Inc. | 34,239,018 | $771,063,000 | 8.08% |
| Crestline Management, LP | 3,210,937 | $72,310,000 | 6.80% |
| SB Management Ltd | 2,209,004 | $49,747,000 | 5.10% |
| Omega Fund Management, LLC | 843,750 | $19,001,000 | 2.13% |
| HARVARD MANAGEMENT CO INC | 1,163,601 | $26,204,000 | 1.54% |
| Alphabet Inc. | 2,812,500 | $63,338,000 | 1.50% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 387,508 | $8,727,000 | 1.03% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 4,131,249 | $93,036,000 | 0.53% |
| Dragoneer Investment Group | 1,500,000 | $33,780,000 | 0.44% |